Compare · CANO vs OPCH
CANO vs OPCH
Side-by-side comparison of Cano Health Inc. (CANO) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CANO and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH is the larger of the two at $3.22B, about 3.4x CANO ($949.0M).
- OPCH has hit the wire 13 times in the past 4 weeks while CANO has been quiet.
- CANO has more recent analyst coverage (22 ratings vs 14 for OPCH).
- Company
- Cano Health Inc.
- Option Care Health Inc.
- Price
- $2.31-1.70%
- $20.07-2.14%
- Market cap
- $949.0M
- $3.22B
- 1M return
- -
- -5.73%
- 1Y return
- -
- -35.86%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 0
- 13
- Recent ratings
- 22
- 14
Cano Health Inc.
Cano Health, LLC owns and operates health care centers and pharmacies. It provides medical, dental, urgent care, an in-house laboratory, and specialty services. The company offers patient-centric programs, such as home visits, telehealth, transition of care, and high risk and complex care management. Cano Health, LLC was founded in 2009 and is based in Miami, Florida.
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest CANO
- Cano Health Announces Agreement with Unsecured Creditors Committee and Court Approval of Disclosure Statement for its Reorganization Plan
- SEC Form SC 13G/A filed by Cano Health Inc. (Amendment)
- Cano Health Inc. filed SEC Form 8-K: Regulation FD Disclosure
- SEC Form SC 13D/A filed by Cano Health Inc. (Amendment)
- Cano Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
- SEC Form 25-NSE filed by Cano Health Inc.
- SEC Form 8-K filed by Cano Health Inc.
- NYSE Suspends Trading n Cano Health And Begins Delisting Proceedings
- NYSE Suspends Trading in Cano Health, Inc. (CANO) and Commences Delisting Proceedings
- Cano Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure
Latest OPCH
- Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
- Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
- Director Bierbower Elizabeth D was granted 8,997 shares, increasing direct ownership by 38% to 32,871 units (SEC Form 4)
- Director Deckmann Natasha was granted 9,841 shares, increasing direct ownership by 44% to 32,002 units (SEC Form 4)
- Director Kraemer Harry M Jansen Jr was granted 21,076 shares, increasing direct ownership by 5% to 471,076 units (SEC Form 4)
- Director Pate R Carter was granted 8,997 shares, increasing direct ownership by 77% to 20,620 units (SEC Form 4)
- Director Sullivan Timothy P was granted 13,833 shares, increasing direct ownership by 19% to 87,216 units (SEC Form 4)
- Director Bodem Barbara W. was granted 8,997 shares, increasing direct ownership by 74% to 21,087 units (SEC Form 4)
- Director Wright Norman L. was granted 8,997 shares, increasing direct ownership by 58% to 24,498 units (SEC Form 4)
- Director Brandt Eric was granted 11,640 shares, increasing direct ownership by 112% to 21,999 units (SEC Form 4)